Allergy/Asthma News

SAN DIEGO — New data showed Vtama cream achieved consistent and strong efficacy for the treatment of atopic dermatitis across all racial groups, according to a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.

An analysis of global online conversations among health care professionals on social media in February showed an overarching sense of enthusiasm about FDA approval of the first cellular therapy to treat unresectable or metastatic melanoma.

WASHINGTON — An intervention increased the number of patients with a penicillin allergy label who were referred to an allergist, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Patients with food allergy who used omalizumab experienced increased thresholds for reacting to peanut and other foods to which they were allergic, according to a study published in The New England Journal of Medicine.

A high risk for asthma in children was linked to increased levels of fine particulate matter and nitrogen dioxide exposure in the first 3 years of life, according to results published in JAMA Network Open.

Between dupilumab, benralizumab and mepolizumab, patients with difficult-to-control asthma had the lowest rate of exacerbations in the first year of dupilumab, according to results published in Annals of the American Thoracic Society.

WASHINGTON — Allergy labels for iodinated contrast media were associated with increased mortality rates, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual meeting.

Despite blood eosinophils depletion, benralizumab did not show a clinical benefit over placebo in chronic spontaneous urticaria, according to a phase 2b trial.

WASHINGTON — Failing to understand basic employment law is one of the most common mistakes that practices make, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — The most effective treatments for atopic dermatitis may also be the most harmful, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.